ERBITUX
Active substance: cetuximab
SOLUTION · CETUXIMAB 2 mg/mL
United StatesActive
Marketing holder: ImClone LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- CETUXIMAB · 2 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 5 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-525d-719c-b36d-b6dfe91710a1,01a120c3-d460-749a-9809-52e651488f69,01a120c4-11e9-715b-abfe-b9f00368424d;count=3 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-b291-7bb5-a9ba-3c1a544f35e6,01a1209d-f166-7a30-abaf-8f92f1ea20ca;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 66733-948
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 66733-948 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 66733-948 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 66733-948 · Verified 2026-10-09 · open in source